NFlection Therapeutics

TODAY IS MAY 17, WORLD NF AWARENESS DAY! Like, share, comment, tag, and shout it from the rooftops: Today's the day we unite our voices around the country and around the world and #MAKENFVISIBLE! NF is a group of genetic disorders that cause tumors to grow on nerves throughout the body. It affects millions of people worldwide, and today is about shining a spotlight on this important cause. By raising awareness about NF, we can support those affected and contribute to ongoing research efforts. Visit makenfvisible.org for more NF facts, Stories of NF, infographics & brochures, videos, and so much more!

Congratulations to the NFlection team and collaborators on the publication of pre-clinical and Phase 2a clinical study results in Science Advances! (https://lnkd.in/gwmb6pYz) Kavita Sarin, Mark Bradshaw, Chris O'Mara, MBA, MS, Jahanbanoo Shahryari, John Kincaid, Steve Kempers, John H Tu, sunil dhawan, Janet DuBois, David Wilson, Patrice Horwath, Mark de Souza, Christopher Powala, Gerd Kochendoerfer, Scott Plotkin, Guy Webster, Lu Le

NFlection supports Rare Disease Day! #rarediseaseday #raredisease

NF1 Patients and Caregivers: Please join us for a presentation of the Phase 2b Clinical Trial Results of NFX-179 Gel for the treatment of cutaneous neurofibromas in neurofibromatosis type 1.

NF1 Healthcare Providers, we hope you can attend our event to discuss the results of our Phase 2b clinical trial and learn about our Phase 3 plans. Patients and Caregivers, please join us at our event on January 18th @ 8:00pm EST.

REGISTRATION IS OPEN FOR THE 2024 GLOBAL NF CONFERENCE IN BRUSSELS! 🌐 https://nfconference.org 🌐 This is the foremost assembly defining the scientific and medical future of NF. Be there with 1,000 attendees for up-to-date knowledge and insights in the growing fields of neurofibromatosis and schwannomatosis. 🗓️ June 20-25, 2024 🌏 The EGG, Brussels 🌐 https://nfconference.org 📝 Abstract submissions accepted through February 15, 2024

The place to be April 11-13, 2024 is San Antonio, TX for the NF Summit, the annual neurofibromatosis and schwannomatosis patient and family gathering! 🗓️ 💙 What can you expect from the agenda? Education, empowerment, networking, connection and a renewed focus on the role of patients and care advocates in advancing NF research, not only as research subjects but as representatives of the NF community. 💚 🎯 Clinical care in NF1, NF2-SWN, and SWN 🎯 Quality of Life, Self Advocacy and Empowerment 🎯 NF Research and You Visit nfsummit.org today to save your seat!

Join us April 11 - 13 in San Antonio, TX! nfsummit.org The annual NF Summit is a place to connect with others who are also on their NF journey. It is a place to learn about what's happening in the world of NF research and treatments, and also to learn from each other. It is a unique opportunity to bond with those who can relate to your own experiences with neurofibromatosis and schwannomatosis. *Applications for scholarships are now being accepted! English ---> https://lnkd.in/g-48x3Vs Spanish ---> https://lnkd.in/gchchmwe #EndNF #MakeNFVisible #nfawareness #nfresearch

NFlection is very pleased to announce positive results from our Phase 2b clinical trial of NFX‑179 Gel in the treatment of cutaneous neurofibromas in people with neurofibromatosis type 1. We want to thank all the study subjects and investigators for their selfless participation and our investors and partners venBio, F-Prime Capital, and the Children's Tumor Foundation for their unwavering support. We look forward to continuing development of NFX-179 for the NF1 community.

NFlection Therapeutics is pleased to announce that our work with Dr. Kenneth Tsai at the Moffitt Cancer Center was published today in Science Translational Medicine. We look forward to continued development in this critical area of medical need.